The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
Closed claims complete the longitudinal patient journey in Truveta Data, enabling regulatory grade safety and effectiveness ...
Private equity investors in health care and life sciences must navigate a complex and shifting landscape influenced by regulatory and policy ...
On January 6, 2025, the FDA released draft guidance on using artificial intelligence (AI) in regulatory decision-making for ...
Investor's Business Daily on MSN3d
Biohaven Just Hurdled An FDA Setback — And Its Moving LinesBiohaven stock hurdled its 50-day and 200-day lines Tuesday after the FDA granted its SCA treatment a speedier review time.
The White House is reportedly considering an executive order to fire thousands of HHS employees. If implemented within the ...
The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...
The International Society for Pharmaceutical Engineering (ISPE) has announced planned featured speakers for the 2025 ISPE Aseptic Conference, taking place Monday, 17 March, through Tuesday, 18 March, ...
Application of AI/ML technology and a burst of M&A activity look to be shaping the future of the pharma industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback